📊 Score Breakdown
Offering Ability
20
Cash Runway
0
Float Risk
15
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for EGBN.
💹 Market Data
Market Cap$827.35M
Shares Outstanding30.50M
Float25.11M
Cash$602.91M
Debt$139.29M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 2.2% shares (2025Q4 vs prior)
185 institutional holders · 26.12M shares
#1
BlackRock, Inc.
3.99M shares
#2
North Reef Capital Management LP
2.94M shares
#3
VANGUARD GROUP INC
1.87M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest2.46M
Days to Cover8.3
% of Float9.8%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 27, 2016
4
INSIDER TRANSACTION
Mar 18, 2026
4
INSIDER TRANSACTION
Mar 18, 2026
4
INSIDER TRANSACTION
Mar 18, 2026
4
INSIDER TRANSACTION
Mar 18, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for EGBN
📊 EGBN FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 EGBN Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.